Skip to content
akaturk Academic measurement
  1. Ana Dal Sağlık Bilimleri Temel Alanı
  2. Yan Dal Tıbbi Onkoloji (İç Hastalıkları)
Articles 36 YÖKSİS 36 · OpenAlex 0 Total citations 123 h-index 4 · OpenAlex OpenAlex coverage %19 matched 7 / 36 Q1 articles 13 Scopus · WoS Q1 10 Best field rank #9,114 / 39,749 Main field · top 22.9% Co-authors 68 10 Turkish institutions

Citation impact

OpenAlex YÖKSİS articles matched in OpenAlex: 7 + YÖKSİS · co-author record: 4
h-index 4 Percentile in Türkiye: 52 #887 of 1,492 at their university by h-index
i10-index
2
Total citations
123
Top 35% in Türkiye
Per article
11.2
FWCI
1.22
1.00 = world average
World top 1%
0
World top 10%
2
How is this computed?

h-index and citations are computed from the citation counts of this academic’s YÖKSİS articles matched in OpenAlex (not Google Scholar, WoS or Scopus). Unmatched articles are not included. 4 articles (9 citations) tagged with this academic’s YÖK author id in co-authors’ YÖKSİS records count only towards citations, h-index and i10; article counts, percentiles and rankings use their own YÖKSİS list.

Citing publications

Crossref 13 publications citing 14 DOI-bearing articles · 1 Türkiye-affiliated

2020 22021 52022 52025 1

  1. Assessing the Influence of Proton Pump Inhibitors on Clinical Outcomes in Hormone Receptor-Positive Metastatic Breast Cancer Patients Receiving CDK4/6 Inhibitors: Evidence from a Ribociclib-Dominant Cohort TR Enes Erul et al. · Medicina · 2025
  2. 10.3389/fgene.2021.673180 2022
  3. 10.1097/prs.0000000000008835 2022
  4. 10.3390/jcm11041067 2022
  5. 10.1093/nar/gkac156 2022
  6. 10.1097/md.0000000000028786 2022
  7. 10.3389/fendo.2021.713700 2021
  8. 10.1016/j.canlet.2021.04.016 2021
  9. 10.5306/wjco.v12.i4.282 2021
  10. 10.1007/978-3-030-65463-4_7 2021
  11. 10.1007/978-3-030-75377-1_6 2021
  12. 10.1200/op.20.00113 2020
  13. 10.1097/md.0000000000021861 2020
Where does this list come from?

Extracted from the reference lists in Crossref’s public March 2026 data file; 18.4% of the file has been processed, so the list may be incomplete. Crossref citations are never added to or compared with the OpenAlex citation counts; the two sources have different coverage.

Field ranking

YÖKSİS ?

Collaboration network

From the author lists of YÖKSİS publication records. Duplicate records of a work count once; institutions are co-authors’ current YÖKSİS affiliations.

Co-authors
68
With an akaturk profile
16
Turkish institutions
10
Co-authored works
%97

Academic co-authors 16

  1. ÖMER DİZDAR Profesör · Hacettepe Üniversitesi 10
  2. HAKAN HARPUTLUOĞLU Profesör · İnönü Üniversitesi 6
  3. DİDEM ŞENER DEDE Profesör · Ankara Yıldırım Beyazıt Üniversitesi 4
  4. GÖKMEN UMUT ERDEM Profesör · Sağlık Bilimleri Üniversitesi same university 4
  5. SERCAN AKSOY Profesör · Hacettepe Üniversitesi 4
  6. OSMAN ERSOY Profesör · Ankara Yıldırım Beyazıt Üniversitesi 2
  7. ARZU OĞUZ Profesör · Başkent Üniversitesi 1
  8. BURÇİN ÇAKAN DEMİREL Doçent · İstanbul Medipol Üniversitesi 1
  9. HAKAN AKBULUT Profesör · Ankara Üniversitesi 1
  10. LEVENT ÖZÇAKAR Profesör · Hacettepe Üniversitesi 1
Show all (16)
  1. SAADETTİN KILIÇKAP Profesör · İstinye Üniversitesi 1
  2. TUBA ÖZGÖÇER Doçent · Harran Üniversitesi 1
  3. ÇAĞATAY ARSLAN Profesör · İzmir Ekonomi Üniversitesi 1
  4. İBRAHİM HALİL GÜLLÜ Profesör · Hacettepe Üniversitesi 1
  5. İHSAN YILMAZ Öğretim Görevlisi (ders Vermekle Görevli) · Manisa Celâl Bayar Üniversitesi 1
  6. İSMAİL ÇELİK Profesör · Hacettepe Üniversitesi 1

National collaboration 10 institutions

Within own university4 joint works · Sağlık Bilimleri Üniversitesi

  1. Hacettepe Üniversitesi 11 works · 5 academics
  2. Ankara Yıldırım Beyazıt Üniversitesi 6 works · 2 academics
  3. İnönü Üniversitesi 6 works · 1 academics
  4. Ankara Üniversitesi 1 works · 1 academics
  5. Başkent Üniversitesi 1 works · 1 academics
  6. Harran Üniversitesi 1 works · 1 academics
  7. Manisa Celâl Bayar Üniversitesi 1 works · 1 academics
  8. İstanbul Medipol Üniversitesi 1 works · 1 academics
  9. İstinye Üniversitesi 1 works · 1 academics
  10. İzmir Ekonomi Üniversitesi 1 works · 1 academics

Other co-authors (incl. international) 52

MUSTAFA KADRİ ALTUNDAĞ 20ebru sarı 6Mehmet Ozen 3TANJU KAPAĞAN 3safa yıldırım 3F karaahmet 2ME tezcan 2YASİN YAVUZ ÖZIŞIK 2erden erdil 2hüseyin demirci 2Özlem yoruk 2A MeralABDİLKERİM OYMANAHMET EMİN ÖZTÜRKARİF İRFAN SOYKANE tezcanEBRU ŞENERKAN DOĞANEZGİ DEĞERLİFU malasG ulusalGAMZE USULH bektasHAMZA ABBASOVIS YildirimK kosemehmetoğluM TosurMEHMET CEM FİDANMEHMET HALICIMERVE TOKOÇİNMEVLÜT KURTMF oztekinMURAD GULİYEVMURAT DİNCERNEBİ SERKAN DEMİRCİOKAN AYDINR CerikciSAİME AYŞE KARST purnakUĞUR ALP YEŞİLOVA

Show all (52)

YAKUP BOZKAYAavcı nilüfercubukcu erdemezgi coşkunmustafa değirmenciolmez ömerfatihpelin algan öcaltuğba kostürkan çetinulaş arifezafer ergulŞAHİN BEDİR

Authors without an akaturk profile (international researchers, retired or former academics, students, clinicians) are grouped by name spelling; short forms such as “Gulluce M.” join the single full name they match.

Indexes and citation percentiles

?
TR Index 3 articles
OpenAlex citation percentile
Top 1%0
Top 10%1
Avg · n 7 %49.3
Other counts

Scopus (SJR)

  • YÖKSİS rows 28

WoS (JCR)

  • YÖKSİS rows 29

Articles

Articles with YÖKSİS and OpenAlex source split; narrow by quartile or TR Index.

36articles

Journals with publications

24 journals

Narrow down

Scopus (SJR)
Q113 Q29 Q36 Q40
WoS (JCR)
TR Index

Article list

  1. 2026 Clinicopathological Predictors of Axillary Pathological Complete Response and Its Prognostic Significance in Clinically Node-Positive (cN+), HER2-Positive Breast Cancer Following Neoadjuvant Therapy MEDICINA-LITHUANIA DOI 10.3390/medicina62010200 YÖKSİS SJR Q2 JCR Q1 OpenAlex 86.1%
  2. 2025 First-Line Chemotherapy Versus CDK4/6 Inhibitors in HR-Positive, HER2-Negative Breast Cancer with Liver Metastases: A Multicenter Real-World Data Journal of Clinical Medicine DOI 10.3390/jcm14134568 YÖKSİS SJR Q2 JCR Q1
  3. 2025 Prognostic impact of histopathological features and serum inflammatory markers in patients with gastric cancer undergoing neoadjuvant therapy World Journal of Gastrointestinal Surgery DOI 10.4240/wjgs.v17.i6.106517 YÖKSİS JCR Q2
  4. 2025 Retro-orbital Metastasis in Chromophobe Renal Cell Carcinoma: A Case Report and Review Archives of Iranian Medicine DOI 10.34172/aim.31231 YÖKSİS SJR Q3 JCR Q2
  5. 2025 Association between metabolic status and nivolumab efficacy in metastatic non-small cell lung cancer: Focus on resting energy expenditure Journal of Oncology Pharmacy Practice DOI 10.1177/10781552251389883 YÖKSİS SJR Q3 JCR Q4
  6. 2023 Polypharmacy and drug-drug interactions in metastatic breast cancer patients receiving cyclin-dependent kinase (CDK) 4/6 inhibitors Journal of Oncology Pharmacy Practice DOI 10.1177/10781552231218959 YÖKSİS SJR Q3 JCR Q4
  7. 2015 Patients with HER2 positive Early Breast Cancer Receiving Adjuvant Trastuzumab Clinicopathological Features Efficacy and Factors Affecting Survival Asian Pacific Journal of Cancer Prevention YÖKSİS SJR Q2 JCR Q3
  8. 2011 Demographic and clinico pathological characteristics in patients with triple negative and non triple negative breast cancer MEDICAL ONCOLOGY DOI 10.1007/s12032-010-9715-9 YÖKSİS SJR Q2 JCR Q3
  9. 2011 Multimodality treatment in the management of anorectal melanoma a case report and review of the literature eurasian journal of medicine YÖKSİS
  10. 2009 Sonographic and electrodiagnostic evaluations in patients with aromatase inhibitor related arthralgia JOURNAL OF CLINICAL ONCOLOGY YÖKSİS SJR Q1 JCR Q1 OpenAlex top 10% OpenAlex 96.6%
  11. 2009 pathological characteristics of very young 30 year breast cancer patients a single institution experience from Turkey ANNALS OF ONCOLOGY YÖKSİS SJR Q1 JCR Q1 OpenAlex 13.5%
  12. 2008 Dasatinib may also inhibit c Kit in triple negative breast cancer cell lines BREAST CANCER RESEARCH AND TREATMENT YÖKSİS SJR Q1 JCR Q1
  13. 2008 Role of trastuzumab in patients with brain metastases from Her2 positive breast cancer JOURNAL OF NEURO-ONCOLOGY YÖKSİS SJR Q1 JCR Q2
  14. 2008 Pure or mixed type invasive lobular carcinoma HUMAN PATHOLOGY YÖKSİS SJR Q1 JCR Q1
  15. 2008 Response to taxanes in triple negative breast cancer CANCER CHEMOTHERAPY AND PHARMACOLOGY YÖKSİS SJR Q1 JCR Q2 OpenAlex 13.0%
  16. 2008 Re Adjuvant chemotherapy with sequential or concurrent anthracycline and docetaxel Breast International Group 02 98 randomized trial JNCI-Journal of the National Cancer Institute YÖKSİS SJR Q1 JCR Q1
  17. 2008 Vitamin D intake may be a predictor of response to aromatase inhibitors in postmenopausal women with hormone receptor positive breast cancer BREAST CANCER RESEARCH AND TREATMENT YÖKSİS SJR Q1 JCR Q1
  18. 2008 Vitamin D supplementation and response to aromatase inhibitors in postmenopausal women with hormone receptor positive breast cancer BREAST YÖKSİS SJR Q1 JCR Q2
  19. 2008 Osteonecrosis of the jaw journal of american dental association YÖKSİS SJR Q1 JCR Q1
  20. 2007 The role of aromatase inhibitors in the management of ductal carcinoma in situ with an estrogen receptor positive progesterone receptor negative Her 2 neu receptor positive pattern american journal of surgery YÖKSİS

← Back to academicians